Sitaxentan

This classification denotes an endothelin-1 protein receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J9QH779MEM. European Medicines Agency schedules Sitaxentan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22917. Sitaxentan generally arises in the molecular formula C18H15CLN2O6S2. The term SITAXENTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 1, 2001, list 45.) Most nations schedule sitaxentan under HS 29350090 and SITC 51580. As of Q4 2014, SITAXENTAN remains the US FDA Preferred Term for this commodity. Sitaxentan bears US NLM identifiers UMLS ID C1704271 and NCI Concept Code C73038. SMILES: CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2.